Berardi F, Colabufo N A, Giudice G, Perrone R, Tortorella V, Govoni S, Lucchi L
Dipartimento Farmaco-chimico, Università di Bari, Italy.
J Med Chem. 1996 Jan 5;39(1):176-82. doi: 10.1021/jm950409c.
Two series of compounds that are structurally related to benzomorphans, derived by structural modification of arylpiperazines with high 5-HT1A affinity and moderate sigma affinity, were prepared in order to increase sigma affinity and selectivity. All new compounds are N-substituted-omega-(1,2,3,4-tetrahydronaphthalen-1-yl)- or -omega-(1,2-dihydronaphthalen-4-yl)-n-alkylamines with, in some cases, a methoxy group on the tetralin moiety. They were tested in radioligand binding assays on sigma ([3H]DTG and [3H]-(+)-pentazocine), D-2 dopaminergic, 5-HT1A and 5-HT2 serotonergic, and PCP (phencyclidine) receptors. A first set of compounds bearing a 4-(1-substituted)piperazine moiety as terminal fragment on the alkyl chain showed moderate to high sigma affinity (Ki = 5.3-139 nM), the most active and selective being 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-n- propyl ]piperazine (14), with probable pronounced sigma 2 affinity (Ki = 5.3 nM on [3H]DTG and Ki = 71 nM on [3H]-(+)-pentazocine). Moreover, compound 13, a 1-benzylpiperazine analogue of 14, preserved a dual high 5-HT1A and sigma affinity (Ki = 3.6 nM on [3H]-5-HT and Ki = 7.0 nM on [3H]DTG). The second set of compounds includes some N-phenylalkyl derivatives of 3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)- n-propylamine that can be considered to be open-chain derivatives of 4-substituted-1-arylpiperazines. Among these compounds that had a lower activity toward sigma binding sites, a high 5-HT1A affinity was found for the N-(3-phenylpropyl) derivative 21 (Ki = 4.4 nM) which demonstrated very good selectivity.
为了提高西格玛亲和力和选择性,制备了两组与苯并吗啡烷结构相关的化合物,它们是通过对具有高5-HT1A亲和力和中等西格玛亲和力的芳基哌嗪进行结构修饰而得到的。所有新化合物都是N-取代的ω-(1,2,3,4-四氢萘-1-基)-或-ω-(1,2-二氢萘-4-基)-正烷基胺,在某些情况下,四氢萘部分带有一个甲氧基。它们在西格玛([3H]DTG和[3H]-(+)-喷他佐辛)、D-2多巴胺能、5-HT1A和5-HT2血清素能以及PCP(苯环己哌啶)受体的放射性配体结合试验中进行了测试。第一组化合物在烷基链末端带有4-(1-取代)哌嗪部分,显示出中等至高的西格玛亲和力(Ki = 5.3-139 nM),其中活性和选择性最高的是1-环己基-4-[3-(5-甲氧基-1,2,3,4-四氢萘-1-基)-正丙基]哌嗪(14),可能具有显著的西格玛2亲和力(在[3H]DTG上Ki = 5.3 nM,在[3H]-(+)-喷他佐辛上Ki = 71 nM)。此外,化合物13是14的1-苄基哌嗪类似物,保留了高5-HT1A和西格玛双重亲和力(在[3H]-5-HT上Ki = 3.6 nM,在[3H]DTG上Ki = 7.0 nM)。第二组化合物包括一些3-(5-甲氧基-1,2,3,4-四氢萘-1-基)-正丙胺的N-苯基烷基衍生物,可以认为是4-取代-1-芳基哌嗪的开链衍生物。在这些对西格玛结合位点活性较低的化合物中,发现N-(3-苯基丙基)衍生物21具有高5-HT1A亲和力(Ki = 4.4 nM),表现出非常好的选择性。